Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions
Authors:
- 1 December 2021
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 228, 107931
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe (70113307)
- Deutsche Forschungsgemeinschaft (BE 5877/2-1)
- Bundesministerium für Forschung, Technologie und Raumfahrt
This publication has 89 references indexed in Scilit:
- Precision cancer mouse models through genome editing with CRISPR-Cas9Genome Medicine, 2015
- Ferret models of viral pathogenesisVirology, 2015
- Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targetsNature Reviews Cardiology, 2014
- Improving the generation of genomic-type transgenic mice by ICSITransgenic Research, 2007
- Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus ReceptorJournal of Virology, 2007
- Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2007
- A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c MicePLOS Pathogens, 2007
- Current issues in mouse genome engineeringNature Genetics, 2005
- Cellular entry of the SARS coronavirusTrends in Microbiology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003